BRPI0508969A - compostos orgánicos - Google Patents

compostos orgánicos

Info

Publication number
BRPI0508969A
BRPI0508969A BRPI0508969-7A BRPI0508969A BRPI0508969A BR PI0508969 A BRPI0508969 A BR PI0508969A BR PI0508969 A BRPI0508969 A BR PI0508969A BR PI0508969 A BRPI0508969 A BR PI0508969A
Authority
BR
Brazil
Prior art keywords
organic compounds
compounds
remedies
formula
preparation
Prior art date
Application number
BRPI0508969-7A
Other languages
English (en)
Inventor
Peter Herold
Stefan Stutz
Robert Mah
Vincenzo Tschinke
Aleksandar Stojanovic
Nathalie Jotterand
Michael Quirmbach
Dirk Behnke
Christiane Marti
Original Assignee
Speedel Experimenta Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Speedel Experimenta Ag filed Critical Speedel Experimenta Ag
Publication of BRPI0508969A publication Critical patent/BRPI0508969A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Abstract

COMPOSTOS ORGáNICOS. A invenção refere-se novos amino ácooios de fórmula geral (I) onde X, R¬ 1¬, R¬ 2¬, R¬ 3¬, R¬ 4¬, R¬ 5¬ e R¬ 6¬ são, cada um,como definidos em detalhes na descrição, a um processo para sua preparação e ao uso destes compostos como remédios, particularmente como inibidores de renina.
BRPI0508969-7A 2004-03-19 2005-03-17 compostos orgánicos BRPI0508969A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH4792004 2004-03-19
PCT/EP2005/051241 WO2005090304A1 (en) 2004-03-19 2005-03-17 Organic compounds

Publications (1)

Publication Number Publication Date
BRPI0508969A true BRPI0508969A (pt) 2007-08-21

Family

ID=34961967

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0508969-7A BRPI0508969A (pt) 2004-03-19 2005-03-17 compostos orgánicos

Country Status (10)

Country Link
US (1) US7868036B2 (pt)
EP (1) EP1725530A1 (pt)
JP (1) JP4927704B2 (pt)
CN (1) CN1934082A (pt)
AR (1) AR048107A1 (pt)
BR (1) BRPI0508969A (pt)
CA (1) CA2560195A1 (pt)
IL (1) IL178099A0 (pt)
TW (1) TW200609215A (pt)
WO (1) WO2005090304A1 (pt)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0505969D0 (en) 2005-03-23 2005-04-27 Novartis Ag Organic compounds
EP1764099A3 (en) * 2005-09-17 2007-05-09 Speedel Experimenta AG Diaminoalcohol derivatives for the treatment of Alzheimer, malaria, HIV
EP1968940B1 (en) 2005-12-30 2014-04-02 Novartis AG 3 , 5-substitued piperidine compounds as renin inhibitors
TW200815324A (en) * 2006-06-23 2008-04-01 Daiichi Sankyo Co Ltd Straight chain amine compound
NZ573720A (en) 2006-06-23 2011-01-28 Daiichi Sankyo Co Ltd Cyclic amine compound
EP2181105B1 (en) 2007-06-25 2015-04-29 Novartis AG N5-(2-ethoxyethyl)-n3-(2-pyridinyl)-3,5-piperidinedicarboxamide derivatives for use as renin inhibitors
DK2975024T3 (en) 2009-06-10 2018-04-23 Chugai Pharmaceutical Co Ltd Tetracyclic compounds
AR077428A1 (es) * 2009-07-29 2011-08-24 Sanofi Aventis (aza) indolizinacarboxamidas ciclicas su preparacion y su uso como agentes farmaceuticos
EP2606886B1 (en) 2010-08-20 2020-01-08 Chugai Seiyaku Kabushiki Kaisha Composition comprising tetracyclic compound
CN111388478A (zh) 2012-09-25 2020-07-10 中外制药株式会社 Ret抑制剂
CN104418835A (zh) * 2013-09-02 2015-03-18 上海龙翔生物医药开发有限公司 一种甲磺酸伊马替尼的制备方法
AR100187A1 (es) 2014-04-25 2016-09-14 Chugai Pharmaceutical Co Ltd Composición farmacéutica que contiene un inhibidor de alk (quinasa de linfoma anaplásico)
US9714229B2 (en) 2014-04-25 2017-07-25 Chugai Seiyaku Kabushiki Kaisha Crystal of tetracyclic compound
TWI765410B (zh) 2014-08-08 2022-05-21 日商中外製藥股份有限公司 ４環性化合物的非晶質體的用途
WO2016114375A1 (ja) 2015-01-16 2016-07-21 中外製薬株式会社 併用医薬
CN112585126B (zh) 2018-09-04 2024-05-07 中外制药株式会社 四环化合物的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY119161A (en) 1994-04-18 2005-04-30 Novartis Ag Delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides with enzyme especially renin inhibiting activities
US5659065A (en) 1994-04-18 1997-08-19 Novartis Corporation Alpha-aminoalkanoic acids and reduction products
US5606078A (en) 1994-04-18 1997-02-25 Ciba-Geigy Corporation 3,5-Disubstituted tetrahydrofuran-2-ones
US8168616B1 (en) * 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
US7312360B2 (en) 2001-12-06 2007-12-25 Elan Pharmaceuticals, Inc. Substituted hydroxyethylamines

Also Published As

Publication number Publication date
US7868036B2 (en) 2011-01-11
JP4927704B2 (ja) 2012-05-09
US20080058320A1 (en) 2008-03-06
EP1725530A1 (en) 2006-11-29
AR048107A1 (es) 2006-03-29
IL178099A0 (en) 2006-12-31
JP2007529473A (ja) 2007-10-25
CN1934082A (zh) 2007-03-21
WO2005090304A1 (en) 2005-09-29
CA2560195A1 (en) 2005-09-29
TW200609215A (en) 2006-03-16

Similar Documents

Publication Publication Date Title
BRPI0508969A (pt) compostos orgánicos
BRPI0510410A (pt) compostos orgánicos
BRPI0510412A (pt) compostos orgánicos
BRPI0512060B8 (pt) compostos orgânicos, composições farmacêuticas compreendendo os mesmos, bem como uso e processo de preparação dos referidos compostos
TW200613274A (en) Organic compounds
BR0316375A (pt) Diazinopirimidinas
BRPI0512986A (pt) novos derivados de hidantoìna
BRPI0506843A (pt) composto, composição farmacêutica, processo para a preparação de um composto, e, uso de um composto
BRPI0206433B8 (pt) composto, composição farmacêutica, e, uso de um composto
BRPI0508610A (pt) derivados de aminoácidos
BR0210616A (pt) Indóis, benzofuranos e benzotiofenos substituìdos com triamida, composição farmacêutica, uso dos referidos compostos, bem como processo para preparação dos mesmos
BRPI0514841A (pt) inibidores de piridila da sinalização de hedgehog, processo de preparação dos mesmos e composição compreendendo os referidos inibidores
BRPI0607455A2 (pt) composto, processo para a preparação do mesmo, uso de um composto, e composição farmacêutica
BRPI0507067A (pt) diamino álcoois e seu uso como inibidores de renina
BRPI0510409A (pt) heterociclos bicìclicos contendo nitrogênio como inibidores da aromatase
CY1109722T1 (el) Ενδιαμεσες ενωσεις για την παρασκευη της trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,73oxepino[4,5-c]pyrrole
BR0108678A (pt) Novos compostos
BRPI0712631A8 (pt) compostos, processos para a preparação de um composto, composição farmacêutica, uso de um composto e combinações
BRPI0720525B8 (pt) inibidores de mapk/erk quinase
DK1599478T3 (da) Dihydropteridinoner, fremgangsmåde til fremstilling af disse og anvendelse af disse som lægemiddel
BRPI0511933B8 (pt) derivados de quinazolinona, seu uso e seu processo de preparação, e composição farmacêutica
BRPI0606964A2 (pt) pirrolidinas e piperidinas derivadas do acetileno para uso como antagonistas de mglur5
BRPI0408888A (pt) processo para a preparação de derivados de 1-n-(fenil)-2-n-(fenil) pirrolidina-1,2-dicarboxamida e derivados de ácido 1-(fenilcarbamoil) pirrolidina-2-carboxìlico como intermediários
DE602006009619D1 (de) Verfahren zur herstellung von 1-amino-3,5-dimethyladamantan-hydrochlorid
NO20090173L (no) Kondensert spiroketalderivat og anvendelse derav som legemiddel for a behandle diabetes

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2204 DE 02/04/2013.